Proton Therapy Center, National Cancer Center, Goyang, Korea.
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):637-46. doi: 10.1016/j.ijrobp.2010.06.039. Epub 2010 Oct 6.
To evaluate the dosimetric benefits of advanced radiotherapy techniques for craniospinal irradiation in cancer in children.
Craniospinal irradiation (CSI) using three-dimensional conformal radiotherapy (3D-CRT), tomotherapy (TOMO), and proton beam treatment (PBT) in the scattering mode was planned for each of 10 patients at our institution. Dosimetric benefits and organ-specific radiation-induced cancer risks were based on comparisons of dose-volume histograms (DVHs) and on the application of organ equivalent doses (OEDs), respectively.
When we analyzed the organ-at-risk volumes that received 30%, 60%, and 90% of the prescribed dose (PD), we found that PBT was superior to TOMO and 3D-CRT. On average, the doses delivered by PBT to the esophagus, stomach, liver, lung, pancreas, and kidney were 19.4 Gy, 0.6 Gy, 0.3 Gy, 2.5 Gy, 0.2 Gy, and 2.2 Gy for the PD of 36 Gy, respectively, which were significantly lower than the doses delivered by TOMO (22.9 Gy, 4.5 Gy, 6.1 Gy, 4.0 Gy, 13.3 Gy, and 4.9 Gy, respectively) and 3D-CRT (34.6 Gy, 3.6 Gy, 8.0 Gy, 4.6 Gy, 22.9 Gy, and 4.3 Gy, respectively). Although the average doses delivered by PBT to the chest and abdomen were significantly lower than those of 3D-CRT or TOMO, these differences were reduced in the head-and-neck region. OED calculations showed that the risk of secondary cancers in organs such as the stomach, lungs, thyroid, and pancreas was much higher when 3D-CRT or TOMO was used than when PBT was used.
Compared with photon techniques, PBT showed improvements in most dosimetric parameters for CSI patients, with lower OEDs to organs at risk.
评估颅脊髓照射(CSI)中先进放疗技术的剂量学优势,以治疗儿童癌症。
为我机构的 10 名患者分别规划了基于三维适形放疗(3D-CRT)、调强放疗(TOMO)和散射模式质子束治疗(PBT)的颅脊髓照射。基于剂量体积直方图(DVH)的比较和器官当量剂量(OED)的应用,分别评估了剂量学获益和器官特异性辐射致癌风险。
当我们分析了接受处方剂量(PD)30%、60%和 90%的危及器官(OAR)体积时,发现 PBT 优于 TOMO 和 3D-CRT。平均而言,PBT 对食管、胃、肝、肺、胰腺和肾脏的剂量分别为 36Gy PD 时的 19.4Gy、0.6Gy、0.3Gy、2.5Gy、0.2Gy 和 2.2Gy,明显低于 TOMO(22.9Gy、4.5Gy、6.1Gy、4.0Gy、13.3Gy 和 4.9Gy)和 3D-CRT(34.6Gy、3.6Gy、8.0Gy、4.6Gy、22.9Gy 和 4.3Gy)。尽管 PBT 对胸部和腹部的平均剂量明显低于 3D-CRT 或 TOMO,但在头颈部区域,这些差异有所减少。OED 计算表明,当使用 3D-CRT 或 TOMO 时,胃、肺、甲状腺和胰腺等器官的二次癌症风险要高得多。
与光子技术相比,PBT 为 CSI 患者提供了大多数剂量学参数的改善,具有更低的 OED。